Global Digital Biomarkers Market By Offerings (Products (Wearables, Mobile Apps, Implantable, Digestible), Services); By Application (Respiratory, Cardiovascular, Neurodegenerative, Mood and Behaviour, Others); By End-User (Pharmaceutical Companies, Payers, Providers, Individuals); By Region (North America (U.S., Canada, Mexico, Rest Of North America), Europe (France, The UK, Spain, Germany, Italy, Denmark, Finland, Iceland, Sweden, Norway, Belgium, The Netherlands, Luxembourg, Rest of Europe), Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia, Rest of Asia Pacific, Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa) Latin America (Brazil, Argentina, Rest of Latin America)) - Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2021 – 2029
Industry Trends
Digital biomarkers are recording of physiological and behavioral data which is collected and measured by using digital devices such as wearables, portables, implantable' and digestibles. The collected data is used to predict health-related outcomes of the patients. Digital biomarkers are increasingly being used for the treatment in therapeutic areas including respiratory diseases, cardiovascular diseases, neurodegenerative diseases, sleep and movement diseases, diabetes, psychiatric diseases, and gastrointestinal diseases. Factors influencing the digital biomarkers market growth include growing incidences of chronic diseases, increasing expenses on healthcare facilities, rising activities around development of drugs and rising geriatric population. Increasing funding in the field of research and development is another factor which is significantly aiding for its market growth. Biomarkers are being increasingly used in the field of medicine, which has aided for improvement in diagnosis, treatment, and monitoring of several areas of diseases. It can be used for identifying patients who are likely to respond to certain drugs or treatment options. This kind of diagnostics is more often used in combination with a drug, particularly for that disease. For example, the Oncomine Dx Target Test by Thermo Fisher Scientific, Inc. which is used for biomarker testing of non-small cell lung cancer checks the eligibility of patients for ROZLYTREK (entrectinib). Thus, such factors are aiding for the digital biomarkers market growth.
Remote patient monitoring (RPM) is now considered as a crucial approach that is supporting healthcare system during the ongoing Covid-19 pandemic. This in turn is propelling the development and validation of digital biomarkers, which helps in identifying patients who are at risk for Covid-19, calculate disease progression as well continuously monitors disease symptoms, mainly using an individual’s device or a smartphone to collect data. For example, if fever can calculate the beginning of the virus, wearable devices with in-built thermometers are likely to be a useful tool in Covid-19 detection. Thus, the Covid-19 pandemic is expected to have a huge impact on the global digital biomarkers market growth.
In terms of revenue, digital biomarkers market was valued at US$ 4521.62 Mn in 2020 and is growing at a CAGR of 25.67% over the forecast period (2021 – 2029). The study analyses the market in terms of revenue across all the major regions, which have been bifurcated into countries.
Digital Biomarkers Market Revenue & Forecast, (US$ Million), 2021 – 2029
By offerings outlook
Based on offerings, the products segment accounted for the highest market share in the digital biomarkers market in 2020. The product segment is divided into wearables, mobile apps, implantable, and digestible. The consumables segment of the digital biomarkers market accounted for the largest market share in 2020. The development of this segment can be attributed to the repeated purchase of consumables and increasing use of kit-based products for biomarker testing.
End-User Outlook
By end-user, pharmaceutical companies accounted for the highest market share in the digital biomarkers market in 2020. Digital biomarkers are very much important for the pharmaceutical companies’ aid for the development of medicines/drugs. The early phases of drug development mostly need the help of digital biomarkers as it is very much important for pharmaceutical scientists to know whether the drug will be effective or not. The drug is then sent to phase III for further trail progress and for the validation of findings of the drug. For example in the case of drug development for Alzheimer’s and Parkinson’s disease, before phase III trial of the drug the effectiveness of the drug for the treatment of these diseases was not determined which had resulted in failure of research and loss of millions of dollars by pharmaceutical firms in the drug development process. Alzheimer’s disease (AD) doubles in occurrence every 5 years after the age 65, and the number of people in the United States is projected to increase from a current 5.5 million to a projected 14 million by the year 2050.
Regional Outlook
By region, North America accounted for the largest market share in 2020 in the digital biomarkers market. The growing concern by government body for the improvement of healthcare infrastructure and the proliferation of smart devices such as smartphones, smartwatches. Furthermore, growing incidences of diseases caused due to sedentary lifestyle is persuading the users to monitor vital signs in order to get a better insight into their health condition. Among North America, U.S. accounted for the largest market revenue in the digital biomarkers market. Availability of strong healthcare infrastructure and increase in funding by the government for improvement and advancements in medical research is boosting the market for digital biomarkers in the U.S.
Competitive Landscape
The report provides both, qualitative and quantitative research of digital biomarkers market, as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by these major market participants are also recognized and analyzed in the report. For each company, the report studies their global presence, competitors, service offerings, and specification amongst others.
Some of the players operating in the digital biomarkers market are AliveCor, Biospective Inc., ConnectedLife Health Pte Ltd, Fitbit LLC. , Happify Health, IXICO plc, NeuroMetrix, Inc., Neurotrack Technologies, Inc., Sonde Health, Inc., and Other Market Participants.
Digital Biomarkers Market
By Offerings
- Products
- Wearables
- Mobile Apps
- Implantable
- Digestible
- Services
By End-User
- Pharmaceutical Companies
- Payers
- Providers
- Individuals
By Application
- Respiratory
- Cardiovascular
- Neurodegenerative
- Mood and Behaviour
- Others
By Region
North America
- U.S.
- Canada
- Mexico
- Rest of North America
Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
1. Market Scope
1.1. Market
Segmentation
1.2. Years
Considered
1.2.1. Historic
Years: 2015 - 2019
1.2.2. Base
Year: 2020
1.2.3. Forecast
Years: 2021 – 2029
2. Key Target Audiences
3. Research Methodology
3.1. Primary
Research
3.1.1. Research
Questionnaire
3.1.2. Global
Percentage Breakdown
3.1.3. Primary
Interviews: Key Opinion Leaders (KOLs)
3.2. Secondary
Research
3.2.1. Paid
Databases
3.2.2. Secondary
Sources
3.3. Market
Size Estimates
3.3.1. Top-Down
Approach
3.3.2. Bottom-Up
Approach
3.4. Data
Triangulation Methodology
3.5. Research
Assumptions
4. Recommendations and Insights from AMI’s Perspective**
5. Holistic Overview of Digital Biomarkers Market
6. Market Synopsis:
Digital Biomarkers Market
7. Digital Biomarkers Market Analysis: Qualitative Perspective
7.1. Introduction
7.1.1. Product
Definition
7.1.2. Industry
Development
7.2. Market
Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.2.4. Challenges
7.3. Trends in
Digital Biomarkers Market
7.4. Market
Determinants Radar Chart
7.5. Macro-Economic
and Micro-Economic Indicators: Digital Biomarkers Market
7.6. Impact of
Covid-19 on Digital Biomarkers Market
8. Global Digital Biomarkers Market Analysis and Forecasts, 2021
– 2029
8.1. Overview
8.1.1. Global
Digital Biomarkers Market Revenue (US$ Mn)
8.2. Global
Digital Biomarkers Market Revenue (US$ Mn) and Forecasts, By Offerings
8.2.1. Products
(Definition, Market Estimation and Penetration, 2015 - 2020, Market Estimation
(2015 - 2020), Market Forecast (2021 - 2029), Compound Annual Growth Rate
(CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle East
and Africa, Latin America) and Information on Wearable, Mobile Apps, Implantable,
Digestible)
8.2.1.1. Wearable
8.2.1.2. Mobile Apps
8.2.1.3. Implantable
8.2.1.4. Digestible
8.2.2. Services
8.2.2.1. Definition
8.2.2.2. Market Estimation and Penetration, 2015 - 2020
8.2.2.3. Market Forecast, 2021 - 2029
8.2.2.4. Compound Annual Growth Rate (CAGR)
8.2.2.5. Regional Bifurcation
8.2.2.5.1. North America
8.2.2.5.1.1. Market
Estimation, 2015 - 2020
8.2.2.5.1.2. Market
Forecast, 2021 - 2029
8.2.2.5.2. Europe
8.2.2.5.2.1. Market
Estimation, 2015 - 2020
8.2.2.5.2.2. Market
Forecast, 2021 - 2029
8.2.2.5.3. Asia Pacific
8.2.2.5.3.1. Market
Estimation, 2015 - 2020
8.2.2.5.3.2. Market
Forecast, 2021 - 2029
8.2.2.5.4. Middle East and Africa
8.2.2.5.4.1. Market
Estimation, 2015 - 2020
8.2.2.5.4.2. Market
Forecast, 2021 - 2029
8.2.2.5.5. Latin America
8.2.2.5.5.1. Market
Estimation, 2015 - 2020
8.2.2.5.5.2. Market
Forecast, 2021 - 2029
8.3. Key
Segment for Channeling Investments
8.3.1. By
Offerings
9. Global Digital Biomarkers Market Analysis and Forecasts, 2021
– 2029
9.1. Overview
9.2. Global
Digital Biomarkers Market Revenue (US$ Mn) and Forecasts, By Application
9.2.1. Respiratory
9.2.1.1. Definition
9.2.1.2. Market Estimation and Penetration, 2015 - 2020
9.2.1.3. Market Forecast, 2021 - 2029
9.2.1.4. Compound Annual Growth Rate (CAGR)
9.2.1.5. Regional Bifurcation
9.2.1.5.1. North America
9.2.1.5.1.1. Market
Estimation, 2015 - 2020
9.2.1.5.1.2. Market
Forecast, 2021 - 2029
9.2.1.5.2. Europe
9.2.1.5.2.1. Market
Estimation, 2015 - 2020
9.2.1.5.2.2. Market
Forecast, 2021 - 2029
9.2.1.5.3. Asia Pacific
9.2.1.5.3.1. Market
Estimation, 2015 - 2020
9.2.1.5.3.2. Market
Forecast, 2021 - 2029
9.2.1.5.4. Middle East and Africa
9.2.1.5.4.1. Market
Estimation, 2015 - 2020
9.2.1.5.4.2. Market
Forecast, 2021 - 2029
9.2.1.5.5. Latin America
9.2.1.5.5.1. Market
Estimation, 2015 - 2020
9.2.1.5.5.2. Market
Forecast, 2021 - 2029
9.2.2. Cardiovascular
9.2.2.1. Definition
9.2.2.2. Market Estimation and Penetration, 2015 - 2020
9.2.2.3. Market Forecast, 2021 - 2029
9.2.2.4. Compound Annual Growth Rate (CAGR)
9.2.2.5. Regional Bifurcation
9.2.2.5.1. North America
9.2.2.5.1.1. Market
Estimation, 2015 - 2020
9.2.2.5.1.2. Market
Forecast, 2021 - 2029
9.2.2.5.2. Europe
9.2.2.5.2.1. Market
Estimation, 2015 - 2020
9.2.2.5.2.2. Market
Forecast, 2021 - 2029
9.2.2.5.3. Asia Pacific
9.2.2.5.3.1. Market
Estimation, 2015 - 2020
9.2.2.5.3.2. Market
Forecast, 2021 - 2029
9.2.2.5.4. Middle East and Africa
9.2.2.5.4.1. Market
Estimation, 2015 - 2020
9.2.2.5.4.2. Market
Forecast, 2021 - 2029
9.2.2.5.5. Latin America
9.2.2.5.5.1. Market
Estimation, 2015 - 2020
9.2.2.5.5.2. Market
Forecast, 2021 - 2029
9.2.3. Neurodegenerative
9.2.3.1. Definition
9.2.3.2. Market Estimation and Penetration, 2015 - 2020
9.2.3.3. Market Forecast, 2021 - 2029
9.2.3.4. Compound Annual Growth Rate (CAGR)
9.2.3.5. Regional Bifurcation
9.2.3.5.1. North America
9.2.3.5.1.1. Market
Estimation, 2015 - 2020
9.2.3.5.1.2. Market
Forecast, 2021 - 2029
9.2.3.5.2. Europe
9.2.3.5.2.1. Market
Estimation, 2015 - 2020
9.2.3.5.2.2. Market
Forecast, 2021 - 2029
9.2.3.5.3. Asia Pacific
9.2.3.5.3.1. Market
Estimation, 2015 - 2020
9.2.3.5.3.2. Market
Forecast, 2021 - 2029
9.2.3.5.4. Middle East and Africa
9.2.3.5.4.1. Market
Estimation, 2015 - 2020
9.2.3.5.4.2. Market
Forecast, 2021 - 2029
9.2.3.5.5. Latin America
9.2.3.5.5.1. Market
Estimation, 2015 - 2020
9.2.3.5.5.2. Market
Forecast, 2021 - 2029
9.2.4. Mood and
Behaviour
9.2.4.1. Definition
9.2.4.2. Market Estimation and Penetration, 2015 - 2020
9.2.4.3. Market Forecast, 2021 - 2029
9.2.4.4. Compound Annual Growth Rate (CAGR)
9.2.4.5. Regional Bifurcation
9.2.4.5.1. North America
9.2.4.5.1.1. Market
Estimation, 2015 - 2020
9.2.4.5.1.2. Market
Forecast, 2021 - 2029
9.2.4.5.2. Europe
9.2.4.5.2.1. Market
Estimation, 2015 - 2020
9.2.4.5.2.2. Market
Forecast, 2021 - 2029
9.2.4.5.3. Asia Pacific
9.2.4.5.3.1. Market
Estimation, 2015 - 2020
9.2.4.5.3.2. Market
Forecast, 2021 - 2029
9.2.4.5.4. Middle East and Africa
9.2.4.5.4.1. Market
Estimation, 2015 - 2020
9.2.4.5.4.2. Market
Forecast, 2021 - 2029
9.2.4.5.5. Latin America
9.2.4.5.5.1. Market
Estimation, 2015 - 2020
9.2.4.5.5.2. Market
Forecast, 2021 - 2029
9.2.5. Others
9.2.5.1. Definition
9.2.5.2. Market Estimation and Penetration, 2015 - 2020
9.2.5.3. Market Forecast, 2021 - 2029
9.2.5.4. Compound Annual Growth Rate (CAGR)
9.2.5.5. Regional Bifurcation
9.2.5.5.1. North America
9.2.5.5.1.1. Market
Estimation, 2015 - 2020
9.2.5.5.1.2. Market
Forecast, 2021 - 2029
9.2.5.5.2. Europe
9.2.5.5.2.1. Market
Estimation, 2015 - 2020
9.2.5.5.2.2. Market
Forecast, 2021 - 2029
9.2.5.5.3. Asia Pacific
9.2.5.5.3.1. Market
Estimation, 2015 - 2020
9.2.5.5.3.2. Market
Forecast, 2021 - 2029
9.2.5.5.4. Middle East and Africa
9.2.5.5.4.1. Market
Estimation, 2015 - 2020
9.2.5.5.4.2. Market
Forecast, 2021 - 2029
9.2.5.5.5. Latin America
9.2.5.5.5.1. Market
Estimation, 2015 - 2020
9.2.5.5.5.2. Market
Forecast, 2021 - 2029
9.3. Key
Segment for Channeling Investments
9.3.1. By
Application
10. Global Digital Biomarkers Market Analysis and Forecasts, 2021
– 2029
10.1. Overview
10.2. Global
Digital Biomarkers Market Revenue (US$ Mn) and Forecasts, By End-User
10.2.1. Pharmaceutical
Companies
10.2.1.1. Definition
10.2.1.2. Market Estimation and Penetration, 2015 - 2020
10.2.1.3. Market Forecast, 2021 - 2029
10.2.1.4. Compound Annual Growth Rate (CAGR)
10.2.1.5. Regional Bifurcation
10.2.1.5.1. North America
10.2.1.5.1.1. Market
Estimation, 2015 - 2020
10.2.1.5.1.2. Market
Forecast, 2021 - 2029
10.2.1.5.2. Europe
10.2.1.5.2.1. Market
Estimation, 2015 - 2020
10.2.1.5.2.2. Market
Forecast, 2021 - 2029
10.2.1.5.3. Asia Pacific
10.2.1.5.3.1. Market
Estimation, 2015 - 2020
10.2.1.5.3.2. Market
Forecast, 2021 - 2029
10.2.1.5.4. Middle East and Africa
10.2.1.5.4.1. Market
Estimation, 2015 - 2020
10.2.1.5.4.2. Market
Forecast, 2021 - 2029
10.2.1.5.5. Latin America
10.2.1.5.5.1. Market
Estimation, 2015 - 2020
10.2.1.5.5.2. Market
Forecast, 2021 - 2029
10.2.2. Payers
10.2.2.1. Definition
10.2.2.2. Market Estimation and Penetration, 2015 - 2020
10.2.2.3. Market Forecast, 2021 - 2029
10.2.2.4. Compound Annual Growth Rate (CAGR)
10.2.2.5. Regional Bifurcation
10.2.2.5.1. North America
10.2.2.5.1.1. Market
Estimation, 2015 - 2020
10.2.2.5.1.2. Market
Forecast, 2021 - 2029
10.2.2.5.2. Europe
10.2.2.5.2.1. Market
Estimation, 2015 - 2020
10.2.2.5.2.2. Market
Forecast, 2021 - 2029
10.2.2.5.3. Asia Pacific
10.2.2.5.3.1. Market
Estimation, 2015 - 2020
10.2.2.5.3.2. Market
Forecast, 2021 - 2029
10.2.2.5.4. Middle East and Africa
10.2.2.5.4.1. Market
Estimation, 2015 - 2020
10.2.2.5.4.2. Market
Forecast, 2021 - 2029
10.2.2.5.5. Latin America
10.2.2.5.5.1. Market
Estimation, 2015 - 2020
10.2.2.5.5.2. Market
Forecast, 2021 - 2029
10.2.3. Providers
10.2.3.1. Definition
10.2.3.2. Market Estimation and Penetration, 2015 - 2020
10.2.3.3. Market Forecast, 2021 - 2029
10.2.3.4. Compound Annual Growth Rate (CAGR)
10.2.3.5. Regional Bifurcation
10.2.3.5.1. North America
10.2.3.5.1.1. Market
Estimation, 2015 - 2020
10.2.3.5.1.2. Market
Forecast, 2021 - 2029
10.2.3.5.2. Europe
10.2.3.5.2.1. Market
Estimation, 2015 - 2020
10.2.3.5.2.2. Market
Forecast, 2021 - 2029
10.2.3.5.3. Asia Pacific
10.2.3.5.3.1. Market
Estimation, 2015 - 2020
10.2.3.5.3.2. Market
Forecast, 2021 - 2029
10.2.3.5.4. Middle East and Africa
10.2.3.5.4.1. Market
Estimation, 2015 - 2020
10.2.3.5.4.2. Market
Forecast, 2021 - 2029
10.2.3.5.5. Latin America
10.2.3.5.5.1. Market
Estimation, 2015 - 2020
10.2.3.5.5.2. Market
Forecast, 2021 - 2029
10.2.4. Individuals
10.2.4.1. Definition
10.2.4.2. Market Estimation and Penetration, 2015 - 2020
10.2.4.3. Market Forecast, 2021 - 2029
10.2.4.4. Compound Annual Growth Rate (CAGR)
10.2.4.5. Regional Bifurcation
10.2.4.5.1. North America
10.2.4.5.1.1. Market
Estimation, 2015 - 2020
10.2.4.5.1.2. Market
Forecast, 2021 - 2029
10.2.4.5.2. Europe
10.2.4.5.2.1. Market
Estimation, 2015 - 2020
10.2.4.5.2.2. Market
Forecast, 2021 - 2029
10.2.4.5.3. Asia Pacific
10.2.4.5.3.1. Market
Estimation, 2015 - 2020
10.2.4.5.3.2. Market
Forecast, 2021 - 2029
10.2.4.5.4. Middle East and Africa
10.2.4.5.4.1. Market
Estimation, 2015 - 2020
10.2.4.5.4.2. Market
Forecast, 2021 - 2029
10.2.4.5.5. Latin America
10.2.4.5.5.1. Market
Estimation, 2015 - 2020
10.2.4.5.5.2. Market
Forecast, 2021 - 2029
10.3. Key
Segment for Channeling Investments
10.3.1. By
End-User
11. North America Digital Biomarkers Market Analysis and
Forecasts, 2021 - 2029
11.1. Overview
11.1.1. North
America Digital Biomarkers Market Revenue (US$ Mn)
11.2. North
America Digital Biomarkers Market Revenue (US$ Mn) and Forecasts, By Offerings
11.2.1. Products
11.2.1.1. Wearable
11.2.1.2. Mobile Apps
11.2.1.3. Implantable
11.2.1.4. Digestible
11.2.2. Services
11.3. North
America Digital Biomarkers Market Revenue (US$ Mn) and Forecasts, By
Application
11.3.1. Respiratory
11.3.2. Cardiovascular
11.3.3. Neurodegenerative
11.3.4. Mood
and Behaviour
11.3.5. Others
11.4. North
America Digital Biomarkers Market Revenue (US$ Mn) and Forecasts, By End-User
11.4.1. Pharmaceutical
Companies
11.4.2. Payers
11.4.3. Providers
11.4.4. Individuals
11.5. North
America Digital Biomarkers Market Revenue (US$ Mn) and Forecasts, By Country
11.5.1. U.S
11.5.1.1. U.S Digital Biomarkers Market Revenue (US$ Mn) and Forecasts,
By Offerings
11.5.1.1.1. Products
11.5.1.1.1.1. Wearable
11.5.1.1.1.2. Mobile
Apps
11.5.1.1.1.3. Implantable
11.5.1.1.1.4. Digestible
11.5.1.1.2. Services
11.5.1.2. U.S Digital Biomarkers Market Revenue (US$ Mn) and Forecasts,
By Application
11.5.1.2.1. Respiratory
11.5.1.2.2. Cardiovascular
11.5.1.2.3. Neurodegenerative
11.5.1.2.4. Mood and Behaviour
11.5.1.2.5. Others
11.5.1.3. U.S Digital Biomarkers Market Revenue (US$ Mn) and Forecasts,
By End-User
11.5.1.3.1. Pharmaceutical Companies
11.5.1.3.2. Payers
11.5.1.3.3. Providers
11.5.1.3.4. Individuals
11.5.2. Canada
11.5.2.1. Canada Digital Biomarkers Market Revenue (US$ Mn) and
Forecasts, By Offerings
11.5.2.1.1. Products
11.5.2.1.1.1. Wearable
11.5.2.1.1.2. Mobile
Apps
11.5.2.1.1.3. Implantable
11.5.2.1.1.4. Digestible
11.5.2.1.2. Services
11.5.2.2. Canada Digital Biomarkers Market Revenue (US$ Mn) and
Forecasts, By Application
11.5.2.2.1. Respiratory
11.5.2.2.2. Cardiovascular
11.5.2.2.3. Neurodegenerative
11.5.2.2.4. Mood and Behaviour
11.5.2.2.5. Others
11.5.2.3. Canada Digital Biomarkers Market Revenue (US$ Mn) and
Forecasts, By End-User
11.5.2.3.1. Pharmaceutical Companies
11.5.2.3.2. Payers
11.5.2.3.3. Providers
11.5.2.3.4. Individuals
11.5.3. Mexico
11.5.3.1. Mexico Digital Biomarkers Market Revenue (US$ Mn) and
Forecasts, By Offerings
11.5.3.1.1. Products
11.5.3.1.1.1. Wearable
11.5.3.1.1.2. Mobile
Apps
11.5.3.1.1.3. Implantable
11.5.3.1.1.4. Digestible
11.5.3.1.2. Services
11.5.3.2. Mexico Digital Biomarkers Market Revenue (US$ Mn) and
Forecasts, By Application
11.5.3.2.1. Respiratory
11.5.3.2.2. Cardiovascular
11.5.3.2.3. Neurodegenerative
11.5.3.2.4. Mood and Behaviour
11.5.3.2.5. Others
11.5.3.3. Mexico Digital Biomarkers Market Revenue (US$ Mn) and
Forecasts, By End-User
11.5.3.3.1. Pharmaceutical Companies
11.5.3.3.2. Payers
11.5.3.3.3. Providers
11.5.3.3.4. Individuals
11.5.4. Rest of
North America
11.5.4.1. Rest of North America Digital Biomarkers Market Revenue (US$
Mn) and Forecasts, By Offerings
11.5.4.1.1. Products
11.5.4.1.1.1. Wearable
11.5.4.1.1.2. Mobile
Apps
11.5.4.1.1.3. Implantable
11.5.4.1.1.4. Digestible
11.5.4.1.2. Services
11.5.4.2. Rest of North America Digital Biomarkers Market Revenue (US$
Mn) and Forecasts, By Application
11.5.4.2.1. Respiratory
11.5.4.2.2. Cardiovascular
11.5.4.2.3. Neurodegenerative
11.5.4.2.4. Mood and Behaviour
11.5.4.2.5. Others
11.5.4.3. Rest of North America Digital Biomarkers Market Revenue (US$
Mn) and Forecasts, By End-User
11.5.4.3.1. Pharmaceutical Companies
11.5.4.3.2. Payers
11.5.4.3.3. Providers
11.5.4.3.4. Individuals
11.6. Key
Segment for Channeling Investments
11.6.1. By
Country
11.6.2. By
Offerings
11.6.3. By
Application
11.6.4. By
End-User
12. Europe Digital Biomarkers Market Analysis and Forecasts, 2021
- 2029
12.1. Overview
12.1.1. Europe
Digital Biomarkers Market Revenue (US$ Mn)
12.2. Europe
Digital Biomarkers Market Revenue (US$ Mn) and Forecasts, By Offerings
12.2.1. Products
12.2.1.1. Wearable
12.2.1.2. Mobile Apps
12.2.1.3. Implantable
12.2.1.4. Digestible
12.2.2. Services
12.3. Europe
Digital Biomarkers Market Revenue (US$ Mn) and Forecasts, By Application
12.3.1. Respiratory
12.3.2. Cardiovascular
12.3.3. Neurodegenerative
12.3.4. Mood
and Behaviour
12.3.5. Others
12.4. Europe
Digital Biomarkers Market Revenue (US$ Mn) and Forecasts, By End-User
12.4.1. Pharmaceutical
Companies
12.4.2. Payers
12.4.3. Providers
12.4.4. Individuals
12.5. Europe
Digital Biomarkers Market Revenue (US$ Mn) and Forecasts, By Country
12.5.1. France
12.5.1.1. France Digital Biomarkers Market Revenue (US$ Mn) and
Forecasts, By Offerings
12.5.1.1.1. Products
12.5.1.1.1.1. Wearable
12.5.1.1.1.2. Mobile
Apps
12.5.1.1.1.3. Implantable
12.5.1.1.1.4. Digestible
12.5.1.1.2. Services
12.5.1.2. France Digital Biomarkers Market Revenue (US$ Mn) and
Forecasts, By Application
12.5.1.2.1. Respiratory
12.5.1.2.2. Cardiovascular
12.5.1.2.3. Neurodegenerative
12.5.1.2.4. Mood and Behaviour
12.5.1.2.5. Others
12.5.1.3. France Digital Biomarkers Market Revenue (US$ Mn) and
Forecasts, By End-User
12.5.1.3.1. Pharmaceutical Companies
12.5.1.3.2. Payers
12.5.1.3.3. Providers
12.5.1.3.4. Individuals
12.5.2. The UK
12.5.2.1. The UK Digital Biomarkers Market Revenue (US$ Mn) and
Forecasts, By Offerings
12.5.2.1.1. Products
12.5.2.1.1.1. Wearable
12.5.2.1.1.2. Mobile
Apps
12.5.2.1.1.3. Implantable
12.5.2.1.1.4. Digestible
12.5.2.1.2. Services
12.5.2.2. The UK Digital Biomarkers Market Revenue (US$ Mn) and
Forecasts, By Application
12.5.2.2.1. Respiratory
12.5.2.2.2. Cardiovascular
12.5.2.2.3. Neurodegenerative
12.5.2.2.4. Mood and Behaviour
12.5.2.2.5. Others
12.5.2.3. The UK Digital Biomarkers Market Revenue (US$ Mn) and Forecasts,
By End-User
12.5.2.3.1. Pharmaceutical Companies
12.5.2.3.2. Payers
12.5.2.3.3. Providers
12.5.2.3.4. Individuals
12.5.3. Spain
12.5.3.1. Spain Digital Biomarkers Market Revenue (US$ Mn) and
Forecasts, By Offerings
12.5.3.1.1. Products
12.5.3.1.1.1. Wearable
12.5.3.1.1.2. Mobile
Apps
12.5.3.1.1.3. Implantable
12.5.3.1.1.4. Digestible
12.5.3.1.2. Services
12.5.3.2. Spain Digital Biomarkers Market Revenue (US$ Mn) and
Forecasts, By Application
12.5.3.2.1. Respiratory
12.5.3.2.2. Cardiovascular
12.5.3.2.3. Neurodegenerative
12.5.3.2.4. Mood and Behaviour
12.5.3.2.5. Others
12.5.3.3. Spain Digital Biomarkers Market Revenue (US$ Mn) and
Forecasts, By End-User
12.5.3.3.1. Pharmaceutical Companies
12.5.3.3.2. Payers
12.5.3.3.3. Providers
12.5.3.3.4. Individuals
12.5.4. Germany
12.5.4.1. Germany Digital Biomarkers Market Revenue (US$ Mn) and
Forecasts, By Offerings
12.5.4.1.1. Products
12.5.4.1.1.1. Wearable
12.5.4.1.1.2. Mobile
Apps
12.5.4.1.1.3. Implantable
12.5.4.1.1.4. Digestible
12.5.4.1.2. Services
12.5.4.2. Germany Digital Biomarkers Market Revenue (US$ Mn) and
Forecasts, By Application
12.5.4.2.1. Respiratory
12.5.4.2.2. Cardiovascular
12.5.4.2.3. Neurodegenerative
12.5.4.2.4. Mood and Behaviour
12.5.4.2.5. Others
12.5.4.3. Germany Digital Biomarkers Market Revenue (US$ Mn) and
Forecasts, By End-User
12.5.4.3.1. Pharmaceutical Companies
12.5.4.3.2. Payers
12.5.4.3.3. Providers
12.5.4.3.4. Individuals
12.5.5. Italy
12.5.5.1. Italy Digital Biomarkers Market Revenue (US$ Mn) and Forecasts,
By Offerings
12.5.5.1.1. Products
12.5.5.1.1.1. Wearable
12.5.5.1.1.2. Mobile
Apps
12.5.5.1.1.3. Implantable
12.5.5.1.1.4. Digestible
12.5.5.1.2. Services
12.5.5.2. Italy Digital Biomarkers Market Revenue (US$ Mn) and
Forecasts, By Application
12.5.5.2.1. Respiratory
12.5.5.2.2. Cardiovascular
12.5.5.2.3. Neurodegenerative
12.5.5.2.4. Mood and Behaviour
12.5.5.2.5. Others
12.5.5.3. Italy Digital Biomarkers Market Revenue (US$ Mn) and
Forecasts, By End-User
12.5.5.3.1. Pharmaceutical Companies
12.5.5.3.2. Payers
12.5.5.3.3. Providers
12.5.5.3.4. Individuals
12.5.6. Nordic
Countries
12.5.6.1. Nordic Countries Digital Biomarkers Market Revenue (US$ Mn)
and Forecasts, By Offerings
12.5.6.1.1. Products
12.5.6.1.1.1. Wearable
12.5.6.1.1.2. Mobile
Apps
12.5.6.1.1.3. Implantable
12.5.6.1.1.4. Digestible
12.5.6.1.2. Services
12.5.6.2. Nordic Countries Digital Biomarkers Market Revenue (US$ Mn)
and Forecasts, By Application
12.5.6.2.1. Respiratory
12.5.6.2.2. Cardiovascular
12.5.6.2.3. Neurodegenerative
12.5.6.2.4. Mood and Behaviour
12.5.6.2.5. Others
12.5.6.3. Nordic Countries Digital Biomarkers Market Revenue (US$ Mn)
and Forecasts, By End-User
12.5.6.3.1. Pharmaceutical Companies
12.5.6.3.2. Payers
12.5.6.3.3. Providers
12.5.6.3.4. Individuals
12.5.6.4. Nordic Countries Digital Biomarkers Market Revenue (US$ Mn)
and Forecasts, By Country
12.5.6.4.1. Denmark
12.5.6.4.2. Finland
12.5.6.4.3. Iceland
12.5.6.4.4. Sweden
12.5.6.4.5. Norway
12.5.7. Benelux
Union
12.5.7.1. Benelux Union Digital Biomarkers Market Revenue (US$ Mn) and
Forecasts, By Offerings
12.5.7.1.1. Products
12.5.7.1.1.1. Wearable
12.5.7.1.1.2. Mobile
Apps
12.5.7.1.1.3. Implantable
12.5.7.1.1.4. Digestible
12.5.7.1.2. Services
12.5.7.2. Benelux Union Digital Biomarkers Market Revenue (US$ Mn) and
Forecasts, By Application
12.5.7.2.1. Respiratory
12.5.7.2.2. Cardiovascular
12.5.7.2.3. Neurodegenerative
12.5.7.2.4. Mood and Behaviour
12.5.7.2.5. Others
12.5.7.3. Benelux Union Digital Biomarkers Market Revenue (US$ Mn) and
Forecasts, By End-User
12.5.7.3.1. Pharmaceutical Companies
12.5.7.3.2. Payers
12.5.7.3.3. Providers
12.5.7.3.4. Individuals
12.5.7.4. Benelux Union Digital Biomarkers Market Revenue (US$ Mn) and
Forecasts, By Country
12.5.7.4.1. Belgium
12.5.7.4.2. The Netherlands
12.5.7.4.3. Luxembourg
12.5.8. Rest of
Europe
12.5.8.1. Rest of Europe Digital Biomarkers Market Revenue (US$ Mn) and
Forecasts, By Offerings
12.5.8.1.1. Products
12.5.8.1.1.1. Wearable
12.5.8.1.1.2. Mobile
Apps
12.5.8.1.1.3. Implantable
12.5.8.1.1.4. Digestible
12.5.8.1.2. Services
12.5.8.2. Rest of Europe Digital Biomarkers Market Revenue (US$ Mn) and Forecasts,
By Application
12.5.8.2.1. Respiratory
12.5.8.2.2. Cardiovascular
12.5.8.2.3. Neurodegenerative
12.5.8.2.4. Mood and Behaviour
12.5.8.2.5. Others
12.5.8.3. Rest of Europe Digital Biomarkers Market Revenue (US$ Mn) and
Forecasts, By End-User
12.5.8.3.1. Pharmaceutical Companies
12.5.8.3.2. Payers
12.5.8.3.3. Providers
12.5.8.3.4. Individuals
12.6. Key
Segment for Channeling Investments
12.6.1. By
Country
12.6.2. By
Offerings
12.6.3. By
Application
12.6.4. By
End-User
13. Asia Pacific Digital Biomarkers Market Analysis and
Forecasts, 2021 - 2029
13.1. Overview
13.1.1. Asia
Pacific Digital Biomarkers Market Revenue (US$ Mn)
13.2. Asia
Pacific Digital Biomarkers Market Revenue (US$ Mn) and Forecasts, By Offerings
13.2.1. Products
13.2.1.1. Wearable
13.2.1.2. Mobile Apps
13.2.1.3. Implantable
13.2.1.4. Digestible
13.2.2. Services
13.3. Asia
Pacific Digital Biomarkers Market Revenue (US$ Mn) and Forecasts, By
Application
13.3.1. Respiratory
13.3.2. Cardiovascular
13.3.3. Neurodegenerative
13.3.4. Mood
and Behaviour
13.3.5. Others
13.4. Asia
Pacific Digital Biomarkers Market Revenue (US$ Mn) and Forecasts, By End-User
13.4.1. Pharmaceutical
Companies
13.4.2. Payers
13.4.3. Providers
13.4.4. Individuals
13.5. Asia
Pacific Digital Biomarkers Market Revenue (US$ Mn) and Forecasts, By Country
13.5.1. China
13.5.1.1. China Digital Biomarkers Market Revenue (US$ Mn) and
Forecasts, By Offerings
13.5.1.1.1. Products
13.5.1.1.1.1. Wearable
13.5.1.1.1.2. Mobile
Apps
13.5.1.1.1.3. Implantable
13.5.1.1.1.4. Digestible
13.5.1.1.2. Services
13.5.1.2. China Digital Biomarkers Market Revenue (US$ Mn) and
Forecasts, By Application
13.5.1.2.1. Respiratory
13.5.1.2.2. Cardiovascular
13.5.1.2.3. Neurodegenerative
13.5.1.2.4. Mood and Behaviour
13.5.1.2.5. Others
13.5.1.3. China Digital Biomarkers Market Revenue (US$ Mn) and
Forecasts, By End-User
13.5.1.3.1. Pharmaceutical Companies
13.5.1.3.2. Payers
13.5.1.3.3. Providers
13.5.1.3.4. Individuals
13.5.2. Japan
13.5.2.1. Japan Digital Biomarkers Market Revenue (US$ Mn) and
Forecasts, By Offerings
13.5.2.1.1. Products
13.5.2.1.1.1. Wearable
13.5.2.1.1.2. Mobile
Apps
13.5.2.1.1.3. Implantable
13.5.2.1.1.4. Digestible
13.5.2.1.2. Services
13.5.2.2. Japan Digital Biomarkers Market Revenue (US$ Mn) and
Forecasts, By Application
13.5.2.2.1. Respiratory
13.5.2.2.2. Cardiovascular
13.5.2.2.3. Neurodegenerative
13.5.2.2.4. Mood and Behaviour
13.5.2.2.5. Others
13.5.2.3. Japan Digital Biomarkers Market Revenue (US$ Mn) and
Forecasts, By End-User
13.5.2.3.1. Pharmaceutical Companies
13.5.2.3.2. Payers
13.5.2.3.3. Providers
13.5.2.3.4. Individuals
13.5.3. India
13.5.3.1. India Digital Biomarkers Market Revenue (US$ Mn) and
Forecasts, By Offerings
13.5.3.1.1. Products
13.5.3.1.1.1. Wearable
13.5.3.1.1.2. Mobile
Apps
13.5.3.1.1.3. Implantable
13.5.3.1.1.4. Digestible
13.5.3.1.2. Services
13.5.3.2. India Digital Biomarkers Market Revenue (US$ Mn) and
Forecasts, By Application
13.5.3.2.1. Respiratory
13.5.3.2.2. Cardiovascular
13.5.3.2.3. Neurodegenerative
13.5.3.2.4. Mood and Behaviour
13.5.3.2.5. Others
13.5.3.3. India Digital Biomarkers Market Revenue (US$ Mn) and
Forecasts, By End-User
13.5.3.3.1. Pharmaceutical Companies
13.5.3.3.2. Payers
13.5.3.3.3. Providers
13.5.3.3.4. Individuals
13.5.4. New
Zealand
13.5.4.1. New Zealand Digital Biomarkers Market Revenue (US$ Mn) and
Forecasts, By Offerings
13.5.4.1.1. Products
13.5.4.1.1.1. Wearable
13.5.4.1.1.2. Mobile
Apps
13.5.4.1.1.3. Implantable
13.5.4.1.1.4. Digestible
13.5.4.1.2. Services
13.5.4.2. New Zealand Digital Biomarkers Market Revenue (US$ Mn) and
Forecasts, By Application
13.5.4.2.1. Respiratory
13.5.4.2.2. Cardiovascular
13.5.4.2.3. Neurodegenerative
13.5.4.2.4. Mood and Behaviour
13.5.4.2.5. Others
13.5.4.3. New Zealand Digital Biomarkers Market Revenue (US$ Mn) and
Forecasts, By End-User
13.5.4.3.1. Pharmaceutical Companies
13.5.4.3.2. Payers
13.5.4.3.3. Providers
13.5.4.3.4. Individuals
13.5.5. Australia
13.5.5.1. Australia Digital Biomarkers Market Revenue (US$ Mn) and
Forecasts, By Offerings
13.5.5.1.1. Products
13.5.5.1.1.1. Wearable
13.5.5.1.1.2. Mobile
Apps
13.5.5.1.1.3. Implantable
13.5.5.1.1.4. Digestible
13.5.5.1.2. Services
13.5.5.2. Australia Digital Biomarkers Market Revenue (US$ Mn) and
Forecasts, By Application
13.5.5.2.1. Respiratory
13.5.5.2.2. Cardiovascular
13.5.5.2.3. Neurodegenerative
13.5.5.2.4. Mood and Behaviour
13.5.5.2.5. Others
13.5.5.3. Australia Digital Biomarkers Market Revenue (US$ Mn) and
Forecasts, By End-User
13.5.5.3.1. Pharmaceutical Companies
13.5.5.3.2. Payers
13.5.5.3.3. Providers
13.5.5.3.4. Individuals
13.5.6. South
Korea
13.5.6.1. South Korea Digital Biomarkers Market Revenue (US$ Mn) and
Forecasts, By Offerings
13.5.6.1.1. Products
13.5.6.1.1.1. Wearable
13.5.6.1.1.2. Mobile
Apps
13.5.6.1.1.3. Implantable
13.5.6.1.1.4. Digestible
13.5.6.1.2. Services
13.5.6.2. South Korea Digital Biomarkers Market Revenue (US$ Mn) and
Forecasts, By Application
13.5.6.2.1. Respiratory
13.5.6.2.2. Cardiovascular
13.5.6.2.3. Neurodegenerative
13.5.6.2.4. Mood and Behaviour
13.5.6.2.5. Others
13.5.6.3. South Korea Digital Biomarkers Market Revenue (US$ Mn) and
Forecasts, By End-User
13.5.6.3.1. Pharmaceutical Companies
13.5.6.3.2. Payers
13.5.6.3.3. Providers
13.5.6.3.4. Individuals
13.5.7. Southeast
Asia
13.5.7.1. Southeast Asia Digital Biomarkers Market Revenue (US$ Mn) and
Forecasts, By Offerings
13.5.7.1.1. Products
13.5.7.1.1.1. Wearable
13.5.7.1.1.2. Mobile
Apps
13.5.7.1.1.3. Implantable
13.5.7.1.1.4. Digestible
13.5.7.1.2. Services
13.5.7.2. Southeast Asia Digital Biomarkers Market Revenue (US$ Mn) and
Forecasts, By Application
13.5.7.2.1. Respiratory
13.5.7.2.2. Cardiovascular
13.5.7.2.3. Neurodegenerative
13.5.7.2.4. Mood and Behaviour
13.5.7.2.5. Others
13.5.7.3. Southeast Asia Digital Biomarkers Market Revenue (US$ Mn) and
Forecasts, By End-User
13.5.7.3.1. Pharmaceutical Companies
13.5.7.3.2. Payers
13.5.7.3.3. Providers
13.5.7.3.4. Individuals
13.5.7.4. Southeast Asia Digital Biomarkers Market Revenue (US$ Mn) and
Forecasts, By Country
13.5.7.4.1. Indonesia
13.5.7.4.2. Thailand
13.5.7.4.3. Malaysia
13.5.7.4.4. Singapore
13.5.7.4.5. Rest of Southeast Asia
13.5.8. Rest of
Asia Pacific
13.5.8.1. Rest of Asia Pacific Digital Biomarkers Market Revenue (US$
Mn) and Forecasts, By Offerings
13.5.8.1.1. Products
13.5.8.1.1.1. Wearable
13.5.8.1.1.2. Mobile
Apps
13.5.8.1.1.3. Implantable
13.5.8.1.1.4. Digestible
13.5.8.1.2. Services
13.5.8.2. Rest of Asia Pacific Digital Biomarkers Market Revenue (US$
Mn) and Forecasts, By Application
13.5.8.2.1. Respiratory
13.5.8.2.2. Cardiovascular
13.5.8.2.3. Neurodegenerative
13.5.8.2.4. Mood and Behaviour
13.5.8.2.5. Others
13.5.8.3. Rest of Asia Pacific Digital Biomarkers Market Revenue (US$
Mn) and Forecasts, By End-User
13.5.8.3.1. Pharmaceutical Companies
13.5.8.3.2. Payers
13.5.8.3.3. Providers
13.5.8.3.4. Individuals
13.6. Key
Segment for Channeling Investments
13.6.1. By
Country
13.6.2. By
Offerings
13.6.3. By Application
13.6.4. By
End-User
14. Middle East and Africa Digital Biomarkers Market Analysis and
Forecasts, 2021 - 2029
14.1. Overview
14.1.1. Middle
East and Africa Digital Biomarkers Market Revenue (US$ Mn)
14.2. Middle
East and Africa Digital Biomarkers Market Revenue (US$ Mn) and Forecasts, By
Offerings
14.2.1. Products
14.2.1.1. Wearable
14.2.1.2. Mobile Apps
14.2.1.3. Implantable
14.2.1.4. Digestible
14.2.2. Services
14.3. Middle
East and Africa Digital Biomarkers Market Revenue (US$ Mn) and Forecasts, By
Application
14.3.1. Respiratory
14.3.2. Cardiovascular
14.3.3. Neurodegenerative
14.3.4. Mood
and Behaviour
14.3.5. Others
14.4. Middle
East and Africa Digital Biomarkers Market Revenue (US$ Mn) and Forecasts, By
End-User
14.4.1. Pharmaceutical
Companies
14.4.2. Payers
14.4.3. Providers
14.4.4. Individuals
14.5. Middle
East and Africa Digital Biomarkers Market Revenue (US$ Mn) and Forecasts, By
Country
14.5.1. Saudi
Arabia
14.5.1.1. Saudi Arabia Digital Biomarkers Market Revenue (US$ Mn) and
Forecasts, By Offerings
14.5.1.1.1. Products
14.5.1.1.1.1. Wearable
14.5.1.1.1.2. Mobile
Apps
14.5.1.1.1.3. Implantable
14.5.1.1.1.4. Digestible
14.5.1.1.2. Services
14.5.1.2. Saudi Arabia Digital Biomarkers Market Revenue (US$ Mn) and
Forecasts, By Application
14.5.1.2.1. Respiratory
14.5.1.2.2. Cardiovascular
14.5.1.2.3. Neurodegenerative
14.5.1.2.4. Mood and Behaviour
14.5.1.2.5. Others
14.5.1.3. Saudi Arabia Digital Biomarkers Market Revenue (US$ Mn) and
Forecasts, By End-User
14.5.1.3.1. Pharmaceutical Companies
14.5.1.3.2. Payers
14.5.1.3.3. Providers
14.5.1.3.4. Individuals
14.5.2. UAE
14.5.2.1. UAE Digital Biomarkers Market Revenue (US$ Mn) and Forecasts,
By Offerings
14.5.2.1.1. Products
14.5.2.1.1.1. Wearable
14.5.2.1.1.2. Mobile
Apps
14.5.2.1.1.3. Implantable
14.5.2.1.1.4. Digestible
14.5.2.1.2. Services
14.5.2.2. UAE Digital Biomarkers Market Revenue (US$ Mn) and Forecasts,
By Application
14.5.2.2.1. Respiratory
14.5.2.2.2. Cardiovascular
14.5.2.2.3. Neurodegenerative
14.5.2.2.4. Mood and Behaviour
14.5.2.2.5. Others
14.5.2.3. UAE Digital Biomarkers Market Revenue (US$ Mn) and Forecasts,
By End-User
14.5.2.3.1. Pharmaceutical Companies
14.5.2.3.2. Payers
14.5.2.3.3. Providers
14.5.2.3.4. Individuals
14.5.3. Egypt
14.5.3.1. Egypt Digital Biomarkers Market Revenue (US$ Mn) and
Forecasts, By Offerings
14.5.3.1.1. Products
14.5.3.1.1.1. Wearable
14.5.3.1.1.2. Mobile
Apps
14.5.3.1.1.3. Implantable
14.5.3.1.1.4. Digestible
14.5.3.1.2. Services
14.5.3.2. Egypt Digital Biomarkers Market Revenue (US$ Mn) and
Forecasts, By Application
14.5.3.2.1. Respiratory
14.5.3.2.2. Cardiovascular
14.5.3.2.3. Neurodegenerative
14.5.3.2.4. Mood and Behaviour
14.5.3.2.5. Others
14.5.3.3. Egypt Digital Biomarkers Market Revenue (US$ Mn) and
Forecasts, By End-User
14.5.3.3.1. Pharmaceutical Companies
14.5.3.3.2. Payers
14.5.3.3.3. Providers
14.5.3.3.4. Individuals
14.5.4. Kuwait
14.5.4.1. Kuwait Digital Biomarkers Market Revenue (US$ Mn) and
Forecasts, By Offerings
14.5.4.1.1. Products
14.5.4.1.1.1. Wearable
14.5.4.1.1.2. Mobile
Apps
14.5.4.1.1.3. Implantable
14.5.4.1.1.4. Digestible
14.5.4.1.2. Services
14.5.4.2. Kuwait Digital Biomarkers Market Revenue (US$ Mn) and
Forecasts, By Application
14.5.4.2.1. Respiratory
14.5.4.2.2. Cardiovascular
14.5.4.2.3. Neurodegenerative
14.5.4.2.4. Mood and Behaviour
14.5.4.2.5. Others
14.5.4.3. Kuwait Digital Biomarkers Market Revenue (US$ Mn) and
Forecasts, By End-User
14.5.4.3.1. Pharmaceutical Companies
14.5.4.3.2. Payers
14.5.4.3.3. Providers
14.5.4.3.4. Individuals
14.5.5. South
Africa
14.5.5.1. South Africa Digital Biomarkers Market Revenue (US$ Mn) and
Forecasts, By Offerings
14.5.5.1.1. Products
14.5.5.1.1.1. Wearable
14.5.5.1.1.2. Mobile
Apps
14.5.5.1.1.3. Implantable
14.5.5.1.1.4. Digestible
14.5.5.1.2. Services
14.5.5.2. South Africa Digital Biomarkers Market Revenue (US$ Mn) and
Forecasts, By Application
14.5.5.2.1. Respiratory
14.5.5.2.2. Cardiovascular
14.5.5.2.3. Neurodegenerative
14.5.5.2.4. Mood and Behaviour
14.5.5.2.5. Others
14.5.5.3. South Africa Digital Biomarkers Market Revenue (US$ Mn) and
Forecasts, By End-User
14.5.5.3.1. Pharmaceutical Companies
14.5.5.3.2. Payers
14.5.5.3.3. Providers
14.5.5.3.4. Individuals
14.5.6. Rest of
Middle East & Africa
14.5.6.1. Rest of Middle East & Africa Digital Biomarkers Market
Revenue (US$ Mn) and Forecasts, By Offerings
14.5.6.1.1. Products
14.5.6.1.1.1. Wearable
14.5.6.1.1.2. Mobile
Apps
14.5.6.1.1.3. Implantable
14.5.6.1.1.4. Digestible
14.5.6.1.2. Services
14.5.6.2. Rest of Middle East & Africa Digital Biomarkers Market
Revenue (US$ Mn) and Forecasts, By Application
14.5.6.2.1. Respiratory
14.5.6.2.2. Cardiovascular
14.5.6.2.3. Neurodegenerative
14.5.6.2.4. Mood and Behaviour
14.5.6.2.5. Others
14.5.6.3. Rest of Middle East & Africa Digital Biomarkers Market
Revenue (US$ Mn) and Forecasts, By End-User
14.5.6.3.1. Pharmaceutical Companies
14.5.6.3.2. Payers
14.5.6.3.3. Providers
14.5.6.3.4. Individuals
14.6. Key
Segment for Channeling Investments
14.6.1. By
Country
14.6.2. By
Offerings
14.6.3. By
Application
14.6.4. By
End-User
15. Latin America Digital Biomarkers Market Analysis and
Forecasts, 2021 - 2029
15.1. Overview
15.1.1. Latin
America Digital Biomarkers Market Revenue (US$ Mn)
15.2. Latin
America Digital Biomarkers Market Revenue (US$ Mn) and Forecasts, By Offerings
15.2.1. Products
15.2.1.1. Wearable
15.2.1.2. Mobile Apps
15.2.1.3. Implantable
15.2.1.4. Digestible
15.2.2. Services
15.3. Latin
America Digital Biomarkers Market Revenue (US$ Mn) and Forecasts, By
Application
15.3.1. Respiratory
15.3.2. Cardiovascular
15.3.3. Neurodegenerative
15.3.4. Mood
and Behaviour
15.3.5. Others
15.4. Latin
America Digital Biomarkers Market Revenue (US$ Mn) and Forecasts, By End-User
15.4.1. Pharmaceutical
Companies
15.4.2. Payers
15.4.3. Providers
15.4.4. Individuals
15.5. Latin
America Digital Biomarkers Market Revenue (US$ Mn) and Forecasts, By Country
15.5.1. Brazil
15.5.1.1. Brazil Digital Biomarkers Market Revenue (US$ Mn) and
Forecasts, By Offerings
15.5.1.1.1. Products
15.5.1.1.1.1. Wearable
15.5.1.1.1.2. Mobile
Apps
15.5.1.1.1.3. Implantable
15.5.1.1.1.4. Digestible
15.5.1.1.2. Services
15.5.1.2. Brazil Digital Biomarkers Market Revenue (US$ Mn) and
Forecasts, By Application
15.5.1.2.1. Respiratory
15.5.1.2.2. Cardiovascular
15.5.1.2.3. Neurodegenerative
15.5.1.2.4. Mood and Behaviour
15.5.1.2.5. Others
15.5.1.3. Brazil Digital Biomarkers Market Revenue (US$ Mn) and
Forecasts, By End-User
15.5.1.3.1. Pharmaceutical Companies
15.5.1.3.2. Payers
15.5.1.3.3. Providers
15.5.1.3.4. Individuals
15.5.2. Argentina
15.5.2.1. Argentina Digital Biomarkers Market Revenue (US$ Mn) and
Forecasts, By Offerings
15.5.2.1.1. Products
15.5.2.1.1.1. Wearable
15.5.2.1.1.2. Mobile
Apps
15.5.2.1.1.3. Implantable
15.5.2.1.1.4. Digestible
15.5.2.1.2. Services
15.5.2.2. Argentina Digital Biomarkers Market Revenue (US$ Mn) and
Forecasts, By Application
15.5.2.2.1. Respiratory
15.5.2.2.2. Cardiovascular
15.5.2.2.3. Neurodegenerative
15.5.2.2.4. Mood and Behaviour
15.5.2.2.5. Others
15.5.2.3. Argentina Digital Biomarkers Market Revenue (US$ Mn) and
Forecasts, By End-User
15.5.2.3.1. Pharmaceutical Companies
15.5.2.3.2. Payers
15.5.2.3.3. Providers
15.5.2.3.4. Individuals
15.5.3. Rest of
Latin America
15.5.3.1. Rest of Latin America Digital Biomarkers Market Revenue (US$
Mn) and Forecasts, By Offerings
15.5.3.1.1. Products
15.5.3.1.1.1. Wearable
15.5.3.1.1.2. Mobile
Apps
15.5.3.1.1.3. Implantable
15.5.3.1.1.4. Digestible
15.5.3.1.2. Services
15.5.3.2. Rest of Latin America Digital Biomarkers Market Revenue (US$
Mn) and Forecasts, By Application
15.5.3.2.1. Respiratory
15.5.3.2.2. Cardiovascular
15.5.3.2.3. Neurodegenerative
15.5.3.2.4. Mood and Behaviour
15.5.3.2.5. Others
15.5.3.3. Rest of Latin America Digital Biomarkers Market Revenue (US$
Mn) and Forecasts, By End-User
15.5.3.3.1. Pharmaceutical Companies
15.5.3.3.2. Payers
15.5.3.3.3. Providers
15.5.3.3.4. Individuals
15.6. Key
Segment for Channeling Investments
15.6.1. By
Country
15.6.2. By
Offerings
15.6.3. By
Application
15.6.4. By
End-User
16. Competitive Benchmarking
16.1. Brand
Benchmarking
16.2. Market
Share Analysis, 2020
16.3. Global
Presence and Growth Strategies
16.3.1. Mergers
and Acquisitions
16.3.2. Product
Launches
16.3.3. Investments
Trends
16.3.4. R&D
Initiatives
17. Player Profiles
17.1. Akili Interactive Labs, Inc.
17.1.1. Company
Details
17.1.2. Company
Overview
17.1.3. Product
Offerings
17.1.4. Key
Developments
17.1.5. Financial
Analysis
17.1.6. SWOT
Analysis
17.1.7. Business
Strategies
17.2. AliveCor
17.2.1. Company
Details
17.2.2. Company
Overview
17.2.3. Product
Offerings
17.2.4. Key
Developments
17.2.5. Financial
Analysis
17.2.6. SWOT
Analysis
17.2.7. Business
Strategies
17.3. Altoida Inc.
17.3.1. Company
Details
17.3.2. Company
Overview
17.3.3. Product
Offerings
17.3.4. Key
Developments
17.3.5. Financial
Analysis
17.3.6. SWOT
Analysis
17.3.7. Business
Strategies
17.4. ConnectedLife Health Pte Ltd
17.4.1. Company
Details
17.4.2. Company
Overview
17.4.3. Product
Offerings
17.4.4. Key
Developments
17.4.5. Financial
Analysis
17.4.6. SWOT
Analysis
17.4.7. Business
Strategies
17.5. Evidation Health, Inc
17.5.1. Company
Details
17.5.2. Company
Overview
17.5.3. Product
Offerings
17.5.4. Key
Developments
17.5.5. Financial
Analysis
17.5.6. SWOT
Analysis
17.5.7. Business
Strategies
17.6. F. Hoffmann-La Roche Ltd
17.6.1. Company
Details
17.6.2. Company
Overview
17.6.3. Product
Offerings
17.6.4. Key
Developments
17.6.5. Financial
Analysis
17.6.6. SWOT
Analysis
17.6.7. Business
Strategies
17.7. Fitbit LLC.
17.7.1. Company
Details
17.7.2. Company
Overview
17.7.3. Product
Offerings
17.7.4. Key
Developments
17.7.5. Financial
Analysis
17.7.6. SWOT
Analysis
17.7.7. Business
Strategies
17.8. Happify Health
17.8.1. Company
Details
17.8.2. Company
Overview
17.8.3. Product
Offerings
17.8.4. Key
Developments
17.8.5. Financial
Analysis
17.8.6. SWOT
Analysis
17.8.7. Business
Strategies
17.9. HUMA
17.9.1. Company
Details
17.9.2. Company
Overview
17.9.3. Product
Offerings
17.9.4. Key
Developments
17.9.5. Financial
Analysis
17.9.6. SWOT
Analysis
17.9.7. Business
Strategies
17.10. IXICO plc
17.10.1. Company
Details
17.10.2. Company
Overview
17.10.3. Product
Offerings
17.10.4. Key
Developments
17.10.5. Financial
Analysis
17.10.6. SWOT
Analysis
17.10.7. Business
Strategies
17.11. NeuroMetrix, Inc.
17.11.1. Company
Details
17.11.2. Company
Overview
17.11.3. Product
Offerings
17.11.4. Key
Developments
17.11.5. Financial
Analysis
17.11.6. SWOT
Analysis
17.11.7. Business
Strategies
17.12. Neurotrack Technologies, Inc.
17.12.1. Company
Details
17.12.2. Company
Overview
17.12.3. Product
Offerings
17.12.4. Key
Developments
17.12.5. Financial
Analysis
17.12.6. SWOT
Analysis
17.12.7. Business
Strategies
17.13. Optina Diagnostics
17.13.1. Company
Details
17.13.2. Company
Overview
17.13.3. Product
Offerings
17.13.4. Key
Developments
17.13.5. Financial
Analysis
17.13.6. SWOT
Analysis
17.13.7. Business
Strategies
17.14. Sonde Health, Inc.
17.14.1. Company
Details
17.14.2. Company
Overview
17.14.3. Product
Offerings
17.14.4. Key
Developments
17.14.5. Financial
Analysis
17.14.6. SWOT
Analysis
17.14.7. Business
Strategies
17.15. Verily Life Science LLC
17.15.1. Company
Details
17.15.2. Company
Overview
17.15.3. Product
Offerings
17.15.4. Key
Developments
17.15.5. Financial
Analysis
17.15.6. SWOT
Analysis
17.15.7. Business
Strategies
17.16. Other
Market Participants
18. Key Findings
Note: This ToC is tentative
and can be changed according to the research study conducted during the course
of report completion.
**Exclusive for Multi-User
and Enterprise User.
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
Reach to us
Call us on
+91-74002-42424
Drop us an email at
sales@absolutemarketsinsights.com
Why Absolute Markets Insights?
An effective strategy is the entity that influences a business to stand out of the crowd. An organization with a phenomenal strategy for success dependably has the edge over the rivals in the market. It offers the organizations a head start in planning their strategy. Absolute Market Insights is the new initiation in the industry that will furnish you with the lead your business needs. Absolute Market Insights is the best destination for your business intelligence and analytical solutions; essentially because our qualitative and quantitative sources of information are competent to give one-stop solutions. We inventively combine qualitative and quantitative research in accurate proportions to have the best report, which not only gives the most recent insights but also assists you to grow.